Non-invasive prenatal determination of fetal RhD genotyping from maternal plasma: a preliminary study in Pakistan.

OBJECTIVE To determine the accuracy of the non-invasive pre-natal real-time polymerase chain reaction based fetal RhD genotyping from maternal plasma. STUDY DESIGN Cross-sectional study. PLACE AND DURATION OF STUDY Juma Health Sciences Research Laboratory, The Aga Khan University Hospital, Karachi, from July to December 2008. METHODOLOGY Cell-free plasma DNA from 21 D-negative women with D-positive spouse between 20-39 weeks of gestation was tested for the presence of exon 5 region of RhD gene using real-time polymerase chain reaction. b-globin was employed as the house-keeping gene. Sensitivity and specificity of the real-time PCR-based non-invasive fetal RhD genotyping was obtained by calculating proportion of the D-positive fetuses that were D-positive at birth as well. RESULTS Of the 21 D-negative women 13 and 8 neonates were determined to be D-positive and D-negative, respectively, by serologic studies on cord blood samples at birth. RhD status was correctly determined in 17 of 21 cases. There were three false-positive and one false-negative results. The sensitivity and specificity of the assay was 92.3% (95% CI: 62.1, 99.6) and 62.5% (95% CI: 25.9, 89.8), respectively. The positive and negative predictive value of the assay was 80% (95% CI: 51.4, 94.7) and 83.3% (36.5, 99.1), respectively. CONCLUSION These preliminary results demonstrate the feasibility of non-invasive pre-natal diagnosis of fetal RhD status of D-negative mothers in Pakistan.

[1]  K. Gutensohn,et al.  The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible , 2008, Transfusion.

[2]  Pete Martin,et al.  Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study , 2008, BMJ : British Medical Journal.

[3]  L. Chitty,et al.  Non-invasive prenatal diagnosis and determination of fetal Rh status. , 2008, Seminars in fetal & neonatal medicine.

[4]  L. Chitty,et al.  SAFE—The Special Non‐invasive Advances in Fetal and Neonatal Evaluation Network: aims and achievements , 2008, Prenatal diagnosis.

[5]  R. Yuen,et al.  Hypermethylation of RASSF1A in human and rhesus placentas. , 2007, The American journal of pathology.

[6]  C. E. van der Schoot,et al.  Evaluation of prenatal RHD typing strategies on cell‐free fetal DNA from maternal plasma , 2006, Transfusion.

[7]  Chunming Ding,et al.  Hypermethylated RASSF1A in maternal plasma: A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. , 2006, Clinical chemistry.

[8]  I. Hromadnikova,et al.  Non-invasive Fetal RHD and RHCE Genotyping Using Real-time PCR Testing of Maternal Plasma in RhD-negative Pregnancies , 2005, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[9]  A. Benachi,et al.  Fetal RhD genotyping by maternal serum analysis: a two-year experience. , 2005, American journal of obstetrics and gynecology.

[10]  G. Daniels.  Human Blood Groups (2nd edn) , 2004 .

[11]  G. Daniels,et al.  A Clinical Service in the UK to Predict Fetal Rh (Rhesus) D Blood Group Using Free Fetal DNA in Maternal Plasma , 2004, Annals of the New York Academy of Sciences.

[12]  N. Avent,et al.  Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service , 2002, Transfusion.

[13]  M. Reid.  The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in Africans with the Rh D-negative blood group phenotype , 2001 .

[14]  M. Petrou,et al.  Prenatal diagnosis of beta‐thalassaemia in Pakistan: experience in a Muslim country , 2000, Prenatal diagnosis.

[15]  N M Hjelm,et al.  Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. , 1998, The New England journal of medicine.

[16]  K. Fleming,et al.  PRENATAL SEX DETERMINATION BY DNA AMPLIFICATION FROM MATERNAL PERIPHERAL BLOOD , 1989, The Lancet.

[17]  D. Luthy,et al.  Rh isoimmunization related to amniocentesis. , 1984, American journal of medical genetics.

[18]  F. Stratton,et al.  Human Blood Groups , 1951, Nature.

[19]  G. Daniels,et al.  The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in africans with the Rh D-negative blood group phenotype. , 2000, Blood.